INBS
Intelligent Bio Solutions Inc.Company with tickers: INBS
CIK
1725430
CUSIP
36151G709
Shares Outstanding
2,391,846
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,060,802 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Cost of Revenue | $525,421 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Gross Profit | $535,381 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Expenses | $3,648,177 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | — | ||||
| Operating Income | $-2,947,101 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-2,862,712 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-1.80 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-1.80 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| United Kingdom | $1,061,191 | $2,894,197 | $2,868,027 |
| Other Country | $189,190 | $162,222 | $132,700 |
| Asia Pacific | — | $43,955 | $29,167 |
| Americas | — | $11,407 | $22,638 |
| Australia | $6,491 | — | — |
By Product & Service (USD)
| Component | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Sales Of Goods Cartidges | $724,304 | $1,549,409 | $1,762,153 |
| Sales Of Goods Readers | $335,863 | $938,897 | $711,737 |
| Other Sales | $196,705 | $623,475 | $578,642 |